Background
Alterations in the gut microbiota have been implicated in both HIV infection and cardiovascular disease(CVD). How microbial alterations relate to host immunity and inflammation, and their relationships with cardiac dysfunction, remains largely unknown, especially in the context of HIV.
Methods
We examined associations of gut microbial features(fecal 16S rRNA sequencing) with cardiac dysfunction(left ventricular systolic or diastolic dysfunction, via echocardiography) in 1570 participants(973 women, 68% HIV+; 597 men, 54% HIV+) from the MACS/WIHS Combined Cohort Study. In a subset(397 women and 359 men), we further integrated cardiac dysfunction–associated microbial features(shotgun metagenomic sequencing) with 59 circulating proteomic inflammation markers(Olink platform) in relation to cardiac dysfunction and HIV.
Results
The potentially pathogenic bacteria Streptococcus, Eggerthella, and Copromonas were associated with higher odds of cardiac dysfunction, whereas the beneficial genera Roseburia and Alistipes were associated with lower odds(Fig.1A). Results were consistent in women and men, and those with and without HIV. These cardiac dysfunction-associated bacteria were associated with 23 inflammation markers. Of note, the protective and pathogenic bacteria were linked to distinct modules of inflammation markers: Roseburia was inversely associated with a module including CXCL9(pro-inflammatory chemokine) and TNFRSF9(pro-inflammatory, pro-atherosclerotic, plaque formation), while Streptococcus and Eggerthella were positively associated with a separate module including HGF(mesenchymal cytokine, a biomarker of heart failure risk) and CDCP1(with pro-inflammatory and pro-fibrotic properties)(Fig.1B). The inflammatory signatures of these taxa, except for Copromonas, were also significantly associated with cardiac dysfunction. Notably, we found that HIV+ serostatus, particularly detectable viremia, was associated with lower levels of the beneficial Roseburia and higher levels of microbial-related inflammation markers(e.g., CXCL9, TNFRSF9).
Conclusions
Among women and men living with or at risk of HIV, we identified several gut bacteria, along with related inflammation markers, associated with cardiac dysfunction. Lower abundance of beneficial Roseburia and higher levels of inflammation markers were associated with both HIV serostatus and detectable viral load, suggesting potential mechanistic clues and therapeutic targets for improving cardiac health in people living with HIV.
Table or Figure
